The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled.

Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Acquisition by pharmaceutical company
Represented pharmaceutical company before the Federal Trade Commission in connection with antitrust merger review.  Advised pharmaceutical company on more
Construction of new hospital wing for Department of Veterans Affairs
Represented the general contractor on a new $70 million hospital wing for the Department of Veterans Affairs in Ann Arbor, Michigan. Following a more
Employee benefits advice for one of the nation's largest providers of telephone and broadband services
Advised one of the nation's largest providers of telephone and broadband services with respect to compensation and employee benefit plan issues in a more
Trade secret litigation for provider of video services
Successfully obtained summary judgment for provider of video services to horse racing association stating that its retention of union work force and more